日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT

甲氨蝶呤给药方案对HLA匹配的异基因造血干细胞移植GVHD预防临床结局的影响

Suzuki, Tomotaka; Jo, Tomoyasu; Yoshifuji, Kota; Kondo, Tadakazu; Doki, Noriko; Kanda, Yoshinobu; Nishida, Tetsuya; Onishi, Yasushi; Asada, Noboru; Fukuda, Takahiro; Sawa, Masashi; Hasegawa, Yuta; Serizawa, Kentaro; Ota, Shuichi; Tanaka, Masatsugu; Yoshimitsu, Makoto; Atsuta, Yoshiko; Kanda, Junya

Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study

环孢素单药治疗无需输血的非重型再生障碍性贫血的疗效:一项多中心 II 期研究的结果

Ishiyama, Ken; Yamazaki, Masahide; Maruyama, Hiroyuki; Hosono, Naoko; Yamaguchi, Hiroki; Asada, Noboru; Tanimoto, Kazuki; Sugiura, Hiroyuki; Usuki, Kensuke; Yoshimura, Kenichi; Ogawa, Seishi; Kanakura, Yuzuru; Matsumura, Itaru; Akashi, Koichi; Nakao, Shinji

HLA-matched versus haploidentical donor transplantation with post-transplant cyclophosphamide: a study on behalf of the donor/source working group of the Japanese society for transplantation and cellular therapy

HLA 完全相合与单倍体相合供者移植联合移植后环磷酰胺治疗:日本移植与细胞治疗学会供者/来源工作组的一项研究

Nakaya, Yosuke; Nakamae, Hirohisa; Sugita, Junichi; Kanda, Junya; Hasegawa, Yuta; Eto, Tetsuya; Fukuda, Takahiro; Kurita, Naoki; Hiramoto, Nobuhiro; Nagafuji, Koji; Ota, Shuichi; Asada, Noboru; Ando, Toshihiko; Kawakita, Toshiro; Akasaka, Takashi; Mori, Yasuo; Kamimura, Tomohiko; Onizuka, Makoto; Atsuta, Yoshiko; Nakasone, Hideki

Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantation

异基因造血干细胞移植中HLA纯合单倍型患者的供体选择

Yoshinaga, Noriyoshi; Iwasaki, Makoto; Kato, Koji; Kimura, Fumihiko; Hirayama, Masahiro; Kanaya, Minoru; Morishima, Satoko; Uchida, Naoyuki; Doki, Noriko; Fukuda, Takahiro; Kanda, Yoshinobu; Nishida, Tetsuya; Hasegawa, Yuta; Kako, Shinichi; Tanaka, Masatsugu; Kurokawa, Mineo; Asada, Noboru; Kawakita, Toshiro; Kataoka, Keisuke; Kondo, Yukio; Imada, Kazunori; Ichinohe, Tatsuo; Onizuka, Makoto; Atsuta, Yoshiko; Kanda, Junya

Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease

口腔炎症和微生物群失调会加剧慢性移植物抗宿主病

Kambara, Yui; Fujiwara, Hideaki; Yamamoto, Akira; Gotoh, Kazuyoshi; Tsuji, Shuma; Kunihiro, Mari; Oyama, Tadashi; Terao, Toshiki; Sato, Ayame; Tanaka, Takehiro; Peltier, Daniel; Seike, Keisuke; Nishimori, Hisakazu; Asada, Noboru; Ennishi, Daisuke; Fujii, Keiko; Fujii, Nobuharu; Matsuoka, Ken-Ichi; Soga, Yoshihiko; Reddy, Pavan; Maeda, Yoshinobu

Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft type

根据移植类型,粒细胞集落刺激因子给药对成人急性髓系白血病异基因造血干细胞移植结果的不同影响

Konuma, Takaaki; Kameda, Kazuaki; Morita, Kaoru; Kondo, Tadakazu; Kimura, Fumihiko; Nakasone, Hideki; Ouchi, Fumihiko; Uchida, Naoyuki; Tanaka, Masatsugu; Nishida, Tetsuya; Fukuda, Takahiro; Hasegawa, Yuta; Sakata-Yanagimoto, Mamiko; Onizuka, Makoto; Sawa, Masashi; Ota, Shuichi; Asada, Noboru; Fujiwara, Shin-Ichiro; Yoshihara, Satoshi; Ishimaru, Fumihiko; Yoshimitsu, Makoto; Kanda, Yoshinobu; Ohbiki, Marie; Atsuta, Yoshiko; Yanada, Masamitsu

Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC

完善急性移植物抗宿主病(GVHD)第28天治疗反应标准:JSTCT和MAGIC的合作研究

Akahoshi, Yu; Inamoto, Yoshihiro; Spyrou, Nikolaos; Nakasone, Hideki; Diniz, Marcio A; Asada, Noboru; Ayuk, Francis; Choe, Hannah K; Doki, Noriko; Eto, Tetsuya; Etra, Aaron M; Hexner, Elizabeth O; Hiramoto, Nobuhiro; Hogan, William J; Holler, Ernst; Kataoka, Keisuke; Kawakita, Toshiro; Tanaka, Masatsugu; Tanaka, Takashi; Uchida, Naoyuki; Vasova, Ingrid; Yoshihara, Satoshi; Ishimaru, Fumihiko; Fukuda, Takahiro; Chen, Yi-Bin; Kanda, Junya; Nakamura, Ryotaro; Atsuta, Yoshiko; Ferrara, James L M; Kanda, Yoshinobu; Levine, John E; Teshima, Takanori

A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD.

一项随机对照试验,比较常规 GVHD 预防联合或不联合替普利酮预防严重急性 GVHD 的效果

Kitamura Wataru, Fujii Keiko, Tsuge Mitsuru, Mitsuhashi Toshiharu, Kobayashi Hiroki, Kamoi Chihiro, Yamamoto Akira, Kondo Takumi, Seike Keisuke, Fujiwara Hideaki, Asada Noboru, Ennishi Daisuke, Matsuoka Ken-Ichi, Fujii Nobuharu, Maeda Yoshinobu

Protocol for a multicentre, open-label, dose-escalation phase I/II study evaluating the tolerability, safety, efficacy and pharmacokinetics of repeated continuous intravenous PPMX-T003 in patients with aggressive natural killer cell leukaemia

一项多中心、开放标签、剂量递增的 I/II 期研究方案,旨在评估重复持续静脉注射 PPMX-T003 在侵袭性自然杀伤细胞白血病患者中的耐受性、安全性、有效性和药代动力学。

Fukuhara, Noriko; Onizuka, Makoto; Kanda, Junya; Asada, Noboru; Kato, Koji; Ando, Kiyoshi

Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factors

异基因造血干细胞移植与tisagenlecleucel治疗复发/难治性大B细胞淋巴瘤(R/R LBCL)伴不良预后因素患者的疗效比较

Hayashino, Kenta; Terao, Toshiki; Nishimori, Hisakazu; Kitamura, Wataru; Kobayashi, Hiroki; Kamoi, Chihiro; Seike, Keisuke; Fujiwara, Hideaki; Asada, Noboru; Ennishi, Daisuke; Fujii, Keiko; Fujii, Nobuharu; Matsuoka, Ken-Ichi; Maeda, Yoshinobu